BLT2, a leukotriene B4 receptor 2, as a novel prognostic biomarker of triple-negative breast cancer.
BMB Rep
; 51(8): 373-377, 2018 Aug.
Article
in En
| MEDLINE
| ID: mdl-29898809
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Receptors, Leukotriene B4
/
Triple Negative Breast Neoplasms
Type of study:
Prognostic_studies
Limits:
Female
/
Humans
Language:
En
Journal:
BMB Rep
Journal subject:
BIOLOGIA MOLECULAR
/
BIOQUIMICA
Year:
2018
Document type:
Article
Country of publication: